Why Is End-of-Life Spending So High? Evidence from Cancer Patients

成果类型:
Article
署名作者:
Zeltzer, Dan; Einav, Liran; Finkelstein, Amy; Shir, Tzvi; Stemmer, Salomon M.; Balicer, Ran D.
署名单位:
Tel Aviv University; Stanford University; National Bureau of Economic Research; Massachusetts Institute of Technology (MIT); Clalit Health Services; Rabin Medical Center; Tel Aviv University; Ben-Gurion University of the Negev
刊物名称:
REVIEW OF ECONOMICS AND STATISTICS
ISSN/ISSBN:
0034-6535
DOI:
10.1162/rest_a_01066
发表日期:
2023-05
页码:
511-527
关键词:
health-care utilization medicare beneficiaries last year death site expenditures intensity TRENDS
摘要:
We study the sources of high end-of-life spending for cancer patients. Even among patients with similar initial prognoses, spending in the year postdiagnosis is over twice as high for those who die within the year than those who survive. Elevated spending on decedents is predominantly driven by higher inpatient spending, particularly low-intensity admissions. However, most such admissions do not result in death, making it difficult to target spending reductions. Furthermore, end-of-life spending is substantially more elevated for younger patients, compared to older patients with similar prognoses. Results highlight sources of high end-of-life spending without revealing any natural remedies.
来源URL: